Diffusion Pharmaceuticals... (DFFN)
NASDAQ: DFFN
· Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM
Diffusion Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.93 | 0.00 | -3.02 | -6.2 | 2.89 | -0.81 | -0.00 | 1.91 | -0.49 | -0.81 | -2.11 | -160.71 | -1.6 | -7.38 | -6.11 |
PEG Ratio | 0.03 | -0.00 | -0.03 | n/a | -0.02 | 0.01 | 0.00 | -0.02 | -0.00 | -0.02 | -0.00 | 1.62 | -0.01 | 0.22 | -0.00 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.66 | 1.36 | 1.26 | 1.15 | 2.60 | 0.48 | 0.78 | 0.77 | 0.68 | 0.51 | 1.25 | 63.97 | 2.04 | 2.22 | 2.12 |
P/FCF Ratio | -14.75 | -4.77 | -7.1 | n/a | 11.00 | -2.58 | -2.56 | -4.45 | -5.93 | -3.4 | -8.08 | -738.13 | -26.21 | -33.53 | -21.94 |
P/OCF Ratio | -14.75 | -4.77 | -7.1 | n/a | 11.00 | -2.58 | -2.56 | -4.45 | -5.93 | -3.4 | -8.08 | -738.13 | -26.21 | -33.53 | -21.94 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 |
Quick Ratio | 20.73 | 28.50 | 45.09 | 22.25 | 10.96 | 10.71 | 8.66 | 9.36 | 11.59 | 11.60 | 11.36 | 12.92 | 14.81 | 20.88 | 22.39 |
Current Ratio | 20.73 | 28.50 | 45.09 | 22.25 | 10.96 | 10.71 | 8.66 | 9.36 | 11.59 | 11.60 | 11.36 | 12.92 | 14.81 | 20.88 | 22.39 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | 0.00 | n/a | n/a | n/a | n/a | 0.51 | n/a | 23.44 | n/a | n/a | 23.74 | n/a | n/a | n/a |
Return on Equity | -0.14 | 212.91 | -0.1 | -0.05 | 0.22 | -0.15 | -513.72 | 0.10 | -0.35 | -0.16 | -0.15 | -0.1 | -0.32 | -0.08 | -0.09 |
Return on Assets | -0.13 | 193.74 | -0.1 | -0.04 | 0.18 | -0.13 | -454.38 | 0.09 | -0.32 | -0.14 | -0.13 | -0.09 | -0.3 | -0.07 | -0.08 |
Return on Invested Capital | -0.14 | 147.57 | -0.11 | -0.06 | -0.24 | 161.11 | 2.9K | 0.25 | 0.36 | 159.21 | 148.75 | -0.1 | 0.32 | -0.08 | -0.09 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |